The reassessment of Leqembi’s safety data follows the agency’s previous recommendation of the drug for use in the EU.
The European medicines regulator said on Friday it will review safety information for Eisai and Biogen's Leqembi, nearly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback